Judges Scientific plc
JSCIF
$87.59
$3.093.66%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 185.08M | 176.54M | 170.88M | 170.72M | 170.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 185.08M | 176.54M | 170.88M | 170.72M | 170.71M |
| Cost of Revenue | 60.15M | 53.18M | 48.55M | 48.25M | 47.93M |
| Gross Profit | 124.93M | 123.36M | 122.34M | 122.47M | 122.78M |
| SG&A Expenses | 77.07M | 77.13M | 77.20M | 73.94M | 70.74M |
| Depreciation & Amortization | 24.17M | 23.55M | 23.13M | 23.86M | 24.63M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 161.40M | 153.87M | 148.87M | 146.04M | 143.29M |
| Operating Income | 23.68M | 22.67M | 22.01M | 24.68M | 27.42M |
| Income Before Tax | 17.86M | 17.11M | 16.63M | 18.48M | 20.38M |
| Income Tax Expenses | 2.85M | 2.79M | 2.80M | 3.41M | 4.03M |
| Earnings from Continuing Operations | 15.01 | 14.32 | 13.83 | 15.07 | 16.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -776.60K | -639.30K | -513.80K | -445.90K | -377.30K |
| Net Income | 14.23M | 13.68M | 13.32M | 14.63M | 15.97M |
| EBIT | 23.68M | 22.67M | 22.01M | 24.68M | 27.42M |
| EBITDA | 40.12M | 38.18M | 36.85M | 39.64M | 42.52M |
| EPS Basic | 2.14 | 2.06 | 2.01 | 2.21 | 2.41 |
| Normalized Basic EPS | 1.65 | 1.58 | 1.54 | 1.95 | 2.36 |
| EPS Diluted | 2.11 | 2.03 | 1.97 | 2.17 | 2.37 |
| Normalized Diluted EPS | 1.62 | 1.55 | 1.51 | 1.91 | 2.33 |
| Average Basic Shares Outstanding | 26.57M | 26.55M | 26.54M | 26.52M | 26.49M |
| Average Diluted Shares Outstanding | 27.00M | 27.00M | 26.99M | 26.96M | 26.92M |
| Dividend Per Share | 1.39 | 1.36 | 1.34 | 1.28 | 1.23 |
| Payout Ratio | 58.96% | 61.36% | 63.02% | 53.12% | 44.76% |